Prediction Case File
YouTubeEvaluation Complete

#Nvidia #StockMarket #TechnicalAnalysis #WickedStocks #StockTrading #SwingTrading #NVDA2025

1 extracted signal · 1 resolved · 0 still active

Wicked Stocks profile imageWicked Stocks27 Apr 2026, 21:58 UTC
Video preview for #Nvidia #StockMarket #TechnicalAnalysis #WickedStocks #StockTrading #SwingTrading #NVDA2025
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on NVDA, with a buy signal identified a couple of weeks ago above 194.98. The target price is set at 238.33, anticipated to be reached within the next two to three months, by the end of May. A secondary sign of strength is indicated if the week closes above 212.18. The analysis does not see this as a double top and anticipates the price taking out the current resistance level this week.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Wicked Stocks

Tracked signals
920
Historical success
31.6%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.